文献速递垂体与肾上腺疾病

液相色谱-串联质谱在原发性醛固酮增多症肾上腺静脉采血中表观双侧醛固酮抑制时的价值

The Value of LC-MS/MS in Apparent Bilateral Aldosterone Suppression in Adrenal Venous Sampling for Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究对219例原发性醛固酮增多症患者的肾上腺静脉采血样本用液相色谱-串联质谱(LC-MS/MS)与免疫分析法(IA)同时测定醛固酮和皮质醇,比较表观双侧醛固酮抑制(ABAS)发生率和分型误诊率。未刺激采血中LC-MS/MS较IA降低ABAS发生率(10.7%[17/159] vs 3.1%[5/159]),总体误诊率IA为10.4%(8/77)、LC-MS/MS为9.1%(7/77)。作者认为LC-MS/MS是ABAS发生时的新的解决途径。

要点

  • 未刺激肾上腺静脉采血中,LC-MS/MS较IA降低表观双侧醛固酮抑制发生率(10.7%[17/159] vs 3.1%[5/159])。
  • 有术后结局的77例中,IA与LC-MS/MS分型误诊率分别为10.4%(8/77)与9.1%(7/77)。
  • ABAS患者误诊较非ABAS患者更常见:IA中ABAS者5/6误诊、非ABAS者3/71误诊。

核心结论

  • 作者认为,当表观双侧醛固酮抑制发生时,采用LC-MS/MS测定醛固酮和皮质醇是一种新的解决途径。

研究设计与样本

  • 对219例原发性醛固酮增多症患者的肾上腺静脉采血样本,同时用LC-MS/MS和免疫分析法测定醛固酮与皮质醇并计算ABAS发生率及分型误诊率。
  • 219例中111例接受非促肾上腺皮质激素(非ACTH)刺激采血、60例接受ACTH刺激采血、48例两者均接受。

主要发现

  • 未刺激采血中,LC-MS/MS较IA降低ABAS发生率:10.7%(17/159)vs 3.1%(5/159)。
  • 159例未刺激采血患者中77例有基于术后结局的最终分型诊断,IA与LC-MS/MS误诊率分别为10.4%(8/77)与9.1%(7/77)。
  • IA中ABAS患者6例有5例误诊,非ABAS患者71例有3例误诊。
  • LC-MS/MS中ABAS患者仅1例有随访结局且被误诊,非ABAS患者76例有6例误诊。
  • ACTH刺激采血中观察到相似结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adrenal venous sampling (AVS) is recommended for subtyping primary aldosteronism (PA); however, it is unreliable when apparent bilateral aldosterone suppression (ABAS) occurs, defined as aldosterone/cortisol ratio in the adrenal vein being bilaterally lower than that in the inferior vena cava. The value of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in PA subtyping when ABAS occurs is unclear. OBJECTIVE: This work aimed to determine whether LC-MS/MS can reduce the occurrence of ABAS and misdiagnosis of PA subtyping. METHODS: Aldosterone and cortisol in AVS samples from 219 patients with PA were measured by LC-MS/MS and immunoassay (IA). Then ABAS occurrence and misdiagnosis rate of PA subtyping were calculated. RESULTS: Among 219 patients with PA, 111 and 60 received nonadrenocorticotropin (non-ACTH) and ACTH-stimulated AVS, respectively, and 48 received both. In unstimulated AVS, LC-MS/MS reduced the ABAS occurrence compared to IA (10.7% [17/159] vs 3.1% [5/159]). Among 159 patients with unstimulated AVS, there were 77 patients who had final subtyping diagnosis based on postoperative outcomes. The misdiagnosis rate of IA and LC-MS/MS was 10.4% (8/77) and 9.1% (7/77), respectively. However, misdiagnosis was more common in patients with ABAS than in those without ABAS. For IA, 5 out of 6 ABAS patients were misdiagnosed, while 3/71 non-ABAS patients were misdiagnosed. For LC MS/MS, only one ABAS patient had follow-up outcome and he was misdiagnosed, while 6 of 76 non-ABAS patients were misdiagnosed. Similar results were found in ACTH-stimulated AVS. CONCLUSION: LC-MS/MS measurement of aldosterone and cortisol is a new resolution when ABAS occurs.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li W, Zhou Q, He Y, et al. The Value of LC-MS/MS in Apparent Bilateral Aldosterone Suppression in Adrenal Venous Sampling for Primary Aldosteronism. J Clin Endocrinol Metab. 2025. PMID: 39715354. doi:10.1210/clinem/dgae891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。